Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-HT6 receptor

Details for Australian Patent Application No. 2002236730 (hide)

Owner Eli Lilly and Company

Inventors Krushinski, Joseph, Herman, Junior; Pineiro-Nunez, Marta, Maria; Liu, Bin; Schaus, John, Mehnert; Flaugh, Michael, Edward; Heinz, Lawrence, Joseph; Gillig, James, Ronald; Ward, John, Stanley; Filla, Sandra, Ann

Agent Spruson & Ferguson

Pub. Number AU-B-2002236730

PCT Pub. Number WO2002/060871

Priority 60/264,996 30.01.01 US

Filing date 17 January 2002

Wipo publication date 12 August 2002

Acceptance publication date 15 June 2006

International Classifications

A61K 31/00 (2006.01)

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002236730

15 June 2006 Application Accepted

  Published as AU-B-2002236730

12 October 2006 Standard Patent Sealed

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236731-OXIDIZED COLLAGEN FORMULA- TIONS FOR USE WITH NONCOMPATIBLE PHARMACEUTICAL AGENTS

2002236729-METHODS FOR IMPROVED PLANARIZATION POST CMP PROCESSING